Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$67,848,177
+$33,667,472 QoQ
Shares Held
114,419
+40.3% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 91.60541518454103.ToString("F0")%
Shared 0.ToString("F0")%
None 8.39458481545897.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Sep 30, 2025CallValue
$2,221,813
CallShares
5,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,730,785 | $441,016,092 | |
| 2 | VTRS |
Viatris Inc
|
13,717,622 | $185,325,071 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,826,245 | $145,366,498 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
5,618,728 | $104,058,841 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,409,165 | $73,431,349 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
114,419 | $67,848,177 | |
| 7 | ALKS |
Alkermes plc.
|
1,882,178 | $66,553,812 | |
| 8 | HLN |
Haleon plc
|
6,127,452 | $61,335,793 |
All Filings in UTHR
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67,848,177 | 114,419 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $34,180,705 | 81,536 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $2,221,813 | 5,300 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $20,114,500 | 70,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $42,584,694 | 148,198 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $893,983 | 2,900 | Call | Defined | 2025-06-27 | |
| 2025-03-31 | $23,538,262 | 76,356 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $33,990,840 | 96,335 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $27,714,071 | 77,338 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,710,170 | 80,710 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,433,104 | 58,476 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $23,336,705 | 106,129 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $26,017,738 | 115,189 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $41,280,911 | 187,003 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $30,334,485 | 135,446 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $86,802,734 | 312,139 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $40,667,248 | 194,227 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $48,893,414 | 207,492 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $31,096,775 | 173,328 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $36,533,293 | 169,073 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $52,205,868 | 282,836 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,794,100 | 10,000 | Put | Defined | 2021-08-13 | |
| 2021-06-30 | $1,794,100 | 10,000 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $36,053,157 | 200,954 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $54,089,263 | 323,365 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $58,703,415 | 386,741 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,623,112 | 431,912 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $28,317,388 | 234,028 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,370,750 | 25,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $45,569,892 | 480,543 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $2,370,750 | 25,000 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||